Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia, Myelodysplastic syndrome (MDS)
Results
Phase 1
This trial looked at giving posaconazole in a different way to prevent fungal infection after treatment for acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and chronic myeloid leukaemia (CML).
Recruitment start: 1 October 2011
Recruitment end: 1 August 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Samir Agrawal
Merck Sharp & Dohme Ltd
Schering Plough Research Institute
Last reviewed: 18 Jun 2017
CRUK internal database number: 9215